MentionFox
Home › funding signals › Tropoflex Inc.
Form D · on the record

Tropoflex Inc. — $250K Form D filing, September 2025

Tropoflex Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-22.

Tropoflex Inc. filed a Form D notice of an exempt securities offering with the SEC on September 22, 2025. The filing reports $250K sold. Its industry group is Biotechnology. It names Paul Castella (President & CEO), Bryan Daniels (Director), Kristen Parker (Director) (SEC Form D, September 22, 2025).

Bryan Daniels and 2 others on this filing are also named on 1 other Form D filing ↓

Is this your company?

Key facts

Run the free check on Tropoflex Inc. →

Sell to companies like Tropoflex Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Tropoflex Inc.

New Form D on file · 2025-09-22 · the record

$250K
raise on the record
D
filing
1
investors in
TEXAS
based
Open the record →

What the record says

FilingForm D
Filed2025-09-22
Industry groupBiotechnology
Entity typeCorporation
Incorporated inTEXAS
Year formed2025
BasedSAN ANTONIO, TEXAS
CIK2086856
Accession0002086856-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns Tropoflex Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Tropoflex Inc., from the filings we hold.

The people on this filing

More raises like this

Biotechnology raises by companies based in Texas, filed in September 2025, largest first.

What do you want to do with Tropoflex Inc.?

Get the full cited report on Tropoflex Inc.

What the filing shows about Tropoflex Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Tropoflex Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Tropoflex Inc.'s address as 4725 College Park, Suite 200, San Antonio, TX 78249.

What the filing says

  • Offered: $2,500,000. Sold: $250,000. Left to sell: $2,250,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: September 10, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. It adds: “A portion of proceeds may be used to pay compensation to executive officers.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Tropoflex Inc. See pricing

Is Tropoflex Inc. a real, registered company?

Tropoflex Inc. is a registered filer with the SEC (CIK 2086856) and has filed since 2025-09-22. 1 filing is on record, the latest on 2025-09-22.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Tropoflex Inc.?

Tropoflex Inc.'s Form D of 2025-09-22 names Paul Castella, Bryan Daniels, Kristen Parker and 1 more as its officers, directors or promoters.

How much has Tropoflex Inc. raised?

Its new offerings report $250K sold across 1 offering, as its own filings state.

Biotechnology · by week

Trailing twelve months. 766 filings in Biotechnology, totalled by week.

Want the whole picture on Tropoflex Inc.?

What the filing shows about Tropoflex Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Tropoflex Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Tropoflex Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Tropoflex Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Tropoflex Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Tropoflex Inc.: Raised $250K, Form D filed 2025-09-22
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/tropoflex-inc-form-d-25000001
Last updated 2026-10-30
Primary record: SEC filing 1 · SEC filing 2
Tropoflex Inc. raised $250K — SEC Form D filing, September 2025. MentionFox, 2026-10-30. https://mentionfox.com/funding/tropoflex-inc-form-d-25000001